They showed that higher serum Gal-3 levels were related to a higher cumulative incidence of recurrence (CIR) in patients with AML with t(8;21), suggesting that a high serum Gal-3 level is associated with relapse in these patients. Here, LGALS3 is linked to acute myeloid leukemia.